Full List Of RxTrace Essays Ranked By Year 4 Clicks

Ranking was determined by the total number of pageviews between June 30, 2012 and June 30, 2013.

Rank Title/Link Date Published Comments
1. Anatomy Of The National Drug Code January 3rd, 2012 1
2. The Significance of the Abbott, McKesson and VA Pilot November 12th, 2012 8
3. Will The California ePedigree Dates Slip Again? November 5th, 2012 9
4. IBM Divests EPCIS and ePedigree Suite October 5th, 2012 4
5. The Florida Pedigree Law August 10th, 2009
6. Anatomy of a GTIN January 16th, 2012 9
7. FDA Proposed UDI: The GUDID Database September 10th, 2012 2
8. FDA Proposed UDI: A Revolution In Number Assignment August 20th, 2012 1
9. California Board of Pharmacy Clarifies Use Of GS1 EPCIS December 17th, 2012 2
10. E-Pedigree Vendor Selection February 25th, 2013 10
11. The New GS1 Healthcare US Track & Trace Guidance March 11th, 2013
12. Depicting An NDC Within A GTIN January 23rd, 2012 1
13. InBrief: The Pharma Track & Trace Bill Has Passed the U.S. House Of Representatives June 4th, 2013
14. The Different Goals of Anti-Counterfeiting Technologies and Serialization November 26th, 2012 6
15. RFID is DEAD…at Unit-Level in Pharma April 12th, 2010 15
16. Could It Be The Cloud? More Thoughts On IBM’s Divestiture Of Its EPCIS And E-Pedigree Suite October 8th, 2012 7
17. The New Pharma Track & Trace Discussion Draft In The Senate April 22nd, 2013
18. Congressional Legislation Development: Mad Libs Edition! October 29th, 2012 3
19. California Responds To The Senate Pharma Track & Trace Discussion Draft May 6th, 2013 1
20. Can HIBCC Withstand The GS1 Tide In Medical Device Identification? December 3rd, 2012 5
21. The New Grandfathering Provisions Of The California Pedigree Law March 4th, 2013 1
22. So a customer demands that you use GLN’s and GTIN’s. What next? March 22nd, 2010 2
23. Pharma Anti-Counterfeiting and Serialization November 19th, 2012 1
24. “The Shadows Of Things That MAY BE, Only” : EPCIS and California Compliance January 7th, 2013 1
25. How Pedigrees Protect The Drug Supply: The Case Against Cumberland Distribution January 28th, 2013 4
26. Should GS1 Continue Developing ePedigree Standards? September 17th, 2012 2
27. California ePedigree Uncertainty February 4th, 2013
28. An Industry Protection Bill Concealed Under The Veil Of Patient Protection May 13th, 2013 1
29. The Viability of Global Track & Trace Models May 2nd, 2011 3
30. About
31. The Federal Lot-Based Pedigree Before Congress June 3rd, 2013 7
32. What If RxTEC Isn’t Adopted? March 19th, 2012 5
33. Pharma Aggregation: How Companies Are Achieving Perfection Today March 26th, 2012 7
34. The California ePedigree Timeline Vs. The Senate Bill Timeline June 24th, 2013 1
35. Updated HDMA Bar Code Guidance: A Must Read January 9th, 2012 1
36. InBrief: A Track And Trace Bill Has Made It To The House Floor May 15th, 2013 1
37. Ranbaxy, FDA, FDASIA and Indian Pharma Credibility May 20th, 2013 4
38. Repackaging Drugs Under A Serialization Regulation February 6th, 2012 1
39. FDA Proposed UDI: AIDC Requirements August 27th, 2012
40. The Politics Of Federal Track & Trace Legislation May 29th, 2013 2
41. We Should Be Ashamed Of The U.S. Approach To Pharma Recalls October 22nd, 2012 5
42. The House Hearing on ‘Securing Our Nation’s Prescription Drug Supply Chain’ April 30th, 2013 1
43. Data Ownership In The Track & Trace Cloud January 14th, 2013 3
44. InBrief: A Track & Trace bill Has Made It To The Senate Floor May 22nd, 2013
45. The Supply Chain Provisions Of The FDA Safety & Innovation Act February 11th, 2013 1
46. Q&A With Virginia Herold, Executive Officer, California Board Of Pharmacy April 1st, 2013
47. Standards and Guidance For U.S. Pharma Supply Chain Technology August 6th, 2012 1
48. The Serial Number Handling In Your WMS Probably Isn’t Sufficient For Pharma Serialization April 30th, 2012 2
49. Are Your Drugs Exempt From The California Pedigree Law? March 25th, 2013 6
50. Who Will Decide Which Pedigree Model You Will Invest In? July 30th, 2012 5
51. WAR: GS1 Vs. HIBCC March 15th, 2010 3
52. How Counterfeit Avastin Penetrated the U.S. Supply Chain February 20th, 2012 20
53. Supply Chain Data Synchronization and Patient Safety February 22nd, 2010
54. InBrief: RFID and Barcode Interoperability October 2nd, 2012 2
55. How To Make The Semi-Centralized Track & Trace Model A Reality December 10th, 2012 6
56. The Congressional Draft Proposal to Improve Drug Distribution Security October 25th, 2012 1
57. InBrief: Estimated Rise in Serialized Drugs in The U.S. Supply Chain, 2012 August 1st, 2012 1
58. InBrief: Pharma Supply Chain Criminals Get Justice September 24th, 2012 1
59. More Thoughts On The Congressional Discussion Draft November 1st, 2012 1
60. Draft Regulations On Certifications Within California ePedigrees April 15th, 2013
61. InBrief: FDA Again Says It Plans To Publish Track & Trace Guidance By Year End January 31st, 2013
62. Announcing, Dirk Rodgers Consulting, LLC July 16th, 2012 11
63. Well-Intended Report Calls For Global Track & Trace Of Pharmaceuticals February 18th, 2013 4
64. Contact Dirk
65. Would A U.S. Federal Pedigree Law Require A New UFA? May 28th, 2013 4
66. Why NOW Is The Time To Move Away From Linear Barcodes February 13th, 2012 8
67. The “Normal Distribution” Concept June 21st, 2010
68. How Should Inference Work? January 23rd, 2013 2
69. InBrief: Can ePedigree Be Deferred Until Mid-2016? April 4th, 2013
70. House Subcommittee To Markup Track & Trace Draft Today And Tomorrow May 7th, 2013
71. California’s Draft Inference Regulation April 23rd, 2013
72. Terminology: Track and Trace, and Pedigree October 7th, 2010 2
73. FDA Aligns with GS1 SGTIN For SNDC March 29th, 2010 3
74. Do We Even Need To Mandate Drug Pedigrees Anymore? December 6th, 2010 2
75. U.S. Pharma Supply Chain Complexity May 23rd, 2011 8
76. The Surprise Consequence of the California Pedigree Law March 5th, 2012 10
77. GS1 Standards – Betcha Can’t Use Just One! April 2nd, 2012 3
78. The Board of Pharmacy Must Respond To Ideas For Making EPCIS Work April 8th, 2013
79. Falling Between The Cracks Of The California Pedigree Law June 17th, 2013 2
80. Attributes Of A Global Track & Trace Application February 14th, 2011 6
81. Hey California Board of Pharmacy: Your Time Is Running Out! June 26th, 2013 2
82. Why GS1 EPCIS Alone Won’t Work For California Pedigree, Part 1 October 24th, 2011 2
83. The California Pedigree Law September 7th, 2009 3
84. Walgreens, Automation, And Erasing Disabilities January 16th, 2013 4
85. Should Pharmacies Decommission EPCs Upon Dispense? June 10th, 2013 4
86. Why GS1 EPCIS Alone Won’t Work For California Pedigree, Part 2 November 14th, 2011
87. Your GS1 Company Prefix: An Enterprise Resource April 23rd, 2012 4
88. Anatomy Of An FDA SNI January 30th, 2012 2
89. Will the FDA Accept RFID for Drug Identification? February 27th, 2012 4
90. FAQ’s
91. InBrief: California Board of Pharmacy Webcasts September 5th, 2012
92. Robert J. “Bob” Bergantino (1960-2012) December 10th, 2012 4
93. The Modern Pharmaceutical Wholesaler and the Approaching Transformation May 17th, 2010
94. Pharma Serialization ROI January 3rd, 2011 1
95. Consulting
96. InBrief: CBO Estimates H.R. 1919 Would Exceed Unfunded Mandate Threshold For Private Entities June 3rd, 2013
97. Inference in the Pharmaceutical Supply Chain May 24th, 2010 3
98. InBrief: Illegally Imported Drugs Found To Be Counterfeit…Again February 6th, 2013
99. The Best Laid Plans… March 18th, 2013
100. InBrief: Pharma Supply Chain Community Calls For Solutions To Security Problems February 1st, 2013
101. InBrief: FDA To Publish Track & Trace Standard By Year End March 28th, 2012
102. How To Maximize The ROI Of Attending A Conference October 17th, 2012 2
103. PDUFA Will Not Include RxTEC June 18th, 2012 4
104. Summer News June 20th, 2013 4
105. California’s Draft Regulation on Inspections April 29th, 2013
106. GS1 Identifiers and EPC’s in EDI Messages: Important New HDMA Guidance January 31st, 2011 1
107. California Pedigree Law: Historic Change to Commerce June 14th, 2010 7
108. The Importance of Standards July 12th, 2009 1
109. The Built-in Protections Of The U.S. Pharma Supply Chain May 7th, 2012 13
110. A Semi-Centralized, Semi-Distributed Pedigree System Idea September 27th, 2010 6
111. Pedigree Will Change FOB Terms October 19th, 2010 2
112. A Quick Note About The UDI Conference September 18 & 19, 2012 August 17th, 2012 2
113. Advertise on RxTrace
114. The Future of Traceability Repositories and Inventory Management Systems November 8th, 2010 1
115. Will The Pharma Supply Chain Find Any Value In GS1 Discovery Services? February 8th, 2010 8
116. The Preemption Provisions Built Into The California Pedigree Law June 4th, 2012 10
117. InBrief: ePedigree Models and Points of Failure April 10th, 2012 3
118. Pharmaceutical Anti-Counterfeiting, A First-Rate New Resource September 20th, 2011
119. Three Years of Heat and Light July 9th, 2012 2
120. Home
121. Inspecting An Electronic Pedigree October 31st, 2011 6
122. An Open Letter to GS1, RE: GDSN Marketing May 14th, 2012 5
123. The Good News About Cancer Treatments July 23rd, 2012
124. Could This Be Your Future Track & Trace/ePedigree Exchange Solution? December 5th, 2011 10
125. Celebrating Martin Luther King Jr. January 21st, 2013 1
126. Before You Participate in The GS1 US 2015 Readiness Program, Read This October 4th, 2010 2
127. Return Of Two Classics July 30th, 2012 1
128. Some People Actually WANT To Buy Counterfeit Drugs June 11th, 2012
129. Reliance on Trust in the U.S. Pharma Supply Chain April 26th, 2011 7
130. “Why the rush for GS1 standards?” January 19th, 2010 4
131. California Enforcement Subcommittee Moves To Require FDA SNI March 23rd, 2012 2
132. Lessons from “Drug Theft Goes Big” April 19th, 2011 5
133. Before You Sign Up For GDSN, Get Your Data In Order With A Data Quality Program May 21st, 2012
134. New RxTrace Column in Healthcare Packaging Magazine February 21st, 2013 1
135. Master Data, Supply Chain Master Data and Instance Data September 30th, 2009
136. James “Jim” Dowden (1955? – 2012) May 10th, 2012 5
137. Illegitimate Drugs In The U.S. Supply Chain: Needle In A Haystack June 6th, 2011 1
138. The Abrupt Surge of Interest in Serialization and ePedigree Topics March 12th, 2012 3
139. “The State of Healthcare Logistics” October 7th, 2009 7
140. What are Pedigree Laws Trying to Accomplish Anyway? November 2nd, 2009 6
141. Pelotonia 2012…180 Miles! August 15th, 2012
142. InBrief: Pharma Supply Chain Criminals Get Justice, Part 2 November 21st, 2012
143. Should FDA Cede All Standards Development To GS1? April 16th, 2012 1
144. Charles “Chuck” Schramek (1945 – 2010) January 16th, 2010
145. Estimated Rise In Serialized Drugs In The U.S. Supply Chain August 3rd, 2010 4
146. Plateaus of Pharma Supply Chain Security May 31st, 2011 6
147. Estimated Rise in Serialized Drugs in The U.S. Supply Chain, 2011 August 1st, 2011 1
148. Masterpiece: GS1 Tag Data Standard 1.5 August 30th, 2010
149. Impact of RxUSA v. HHS On Future Pedigree Legislation November 7th, 2011 5
150. Summer Writing June 25th, 2012 3
151. Electronic Message Security and More on Certifications January 24th, 2011
152. Should Regulations Dictate Technology? November 28th, 2011 4
153. Privacy Policy
154. Writing Is Thinking. For Example, Ken Traub November 29th, 2010 3
155. Dangerous Doses July 20th, 2009
156. Who’s Responsible for Global Supply Chain Security? September 21st, 2009 2
157. California Board of Pharmacy Re-awaken September 1st, 2011 3
158. SNI’s Are Not Enough In a Plateau-Based Supply Chain Security Approach June 13th, 2011
159. Will The Pharma Supply Chain Be Able To Use Inference? Maybe Not! June 7th, 2010 13
160. Use of GLN and GTIN for Pedigree Regulatory Compliance November 16th, 2009 3
161. Certifications In A California-Compliant Drug Pedigree October 26th, 2010 6
162. Yifan “Ivan” Shen (1962–2010) August 17th, 2010 26
163. Safe Prescription Drug Reimportation: An Oxymoron October 13th, 2011 1
164. The Legitimate and Illegitimate Supply Chains August 23rd, 2009
165. How to Stop Pharmaceutical Cargo Theft November 29th, 2009
166. The Deputized Supply Chain January 31st, 2010 1
167. Who owns supply chain visibility data? December 31st, 2009 1
168. Innovation and the “Authenticating Wholesaler” Idea May 4th, 2010 5
169. Pew Prescription Project: After Heparin July 18th, 2011 2
170. Digital Signatures August 26th, 2009
171. Partnership For Safe Medicines Interchange 2010 October 12th, 2010 1
172. STEP #1: Raise Penalties For Drug Crimes To Reflect The Widespread Harm They Can Inflict November 21st, 2011 1
173. Welcome to rxTrace July 4th, 2009 1
174. GS1 July 28th, 2009
175. Fundamental Law of Commerce July 8th, 2009
176. Pedigree Models and Supply Chain Master Data October 19th, 2009 3
177. RxTrace: Sophomore Effort July 11th, 2011 1
178. Stop Claiming that 10% of Drugs Worldwide are Counterfeit September 20th, 2010 3
179. PDMA Lawsuit Resolved? November 11th, 2009 1
180. Subscribing to RxTrace August 2nd, 2009
181. RxTrace, One Year Retrospective July 6th, 2010 3
182. New Layout for RxTrace January 13th, 2010
183. Discounts For PSM Interchange 2011 End Next Week September 8th, 2011
184. Happy Holidays 2010 December 17th, 2010 5

…a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance

DISCLAIMER: RxTrace contains some of the personal thoughts, ideas and opinions of Dirk Rodgers. The material contained in RxTrace is not legal advice. Dirk Rodgers is not a lawyer.
The reader must make their own decisions about the accuracy of the opinions expressed in RxTrace. Readers are encouraged to consult their own legal counsel
and trading partners before taking any actions based on information found in RxTrace. RxTrace is not a vehicle for communicating
the positions of any company, organization or individual other than Dirk Rodgers.

RxTrace, a comprehensive exploration of the intersection between healthcare supply chains, track and trace technology, standards and global regulatory compliance.
Contact Us | Privacy Statement
Copyright © 2009-2020 Dirk Rodgers Consulting, LLC. All Rights Reserved.
RxTrace is a registered trademark of Dirk Rodgers Consulting, LLC

SiteLock